Literature DB >> 30863947

Effectiveness of ring pessaries versus vaginal hysterectomy for advanced pelvic organ prolapse. A cohort study.

Alessio Miceli1, José-Luis Dueñas-Diez2,3.   

Abstract

INTRODUCTION AND HYPOTHESIS: This study aimed to evaluate the efficacy of the ring pessary compared with surgery as a primary treatment for advanced pelvic organ prolapse (POP) in non-hysterectomized, postmenopausal women. Our starting hypothesis was that the pessary is as effective as and less risky than surgery.
METHODS: This study was a prospective observational study, which recruited 171 women with symptomatic advanced POP in a tertiary hospital for 30 months. They were treated according their preference with either surgery [77/171 (45.0%)] or vaginal ring pessary without support [94/171 (55.0%)]. The primary outcomes included the discontinuation of pessary use and the incidence of recurrent prolapse throughout the study. Secondary outcomes included complications categorized according to Clavien-Dindo classification. Descriptive statistics were used for demographic data. The mean and standard deviation were calculated for continuous variables, and continuity correction tests, Mann-Whitney U tests, and Fisher's exact tests were used for categorical variables.
RESULTS: There was successful use of a pessary in 84.4% (76/90) of cases, and 89.6% (69/77) of patients did not have prolapse recurrence in the surgical group (>POP-Q 2). In the pessary group, the adverse event rate was 31.6%, and all were Clavien-Dindo grade I. Thirty patients [30/77 (39.0%)] had complications in the surgery group: 14.3% were Clavien-Dindo grade I (11/77), 10.4% were grade II (8/77), and 14.3% were grade III (11/77).
CONCLUSIONS: The pessary is effective and has mild adverse events in non-hysterectomized, postmenopausal women with advanced POP.

Entities:  

Keywords:  Advanced pelvic organ prolapse; Adverse events; Efficacy; Ring pessary without support; Vaginal hysterectomy

Mesh:

Year:  2019        PMID: 30863947     DOI: 10.1007/s00192-019-03919-8

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  26 in total

1.  A survey of pessary use by members of the American urogynecologic society.

Authors:  G W Cundiff; A C Weidner; A G Visco; R C Bump; W A Addison
Journal:  Obstet Gynecol       Date:  2000-06       Impact factor: 7.661

2.  Pessary use in pelvic organ prolapse and urinary incontinence.

Authors:  Keisha A Jones; Oz Harmanli
Journal:  Rev Obstet Gynecol       Date:  2010

3.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

Review 4.  Surgical management of pelvic organ prolapse in women.

Authors:  C Maher; K Baessler; C M A Glazener; E J Adams; S Hagen
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

5.  Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.

Authors:  Theerarat Yimphong; Teerayut Temtanakitpaisan; Pranom Buppasiri; Chompilas Chongsomchai; Supparaluck Kanchaiyaphum
Journal:  Int Urogynecol J       Date:  2017-08-16       Impact factor: 2.894

6.  One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires.

Authors:  Farah Lone; Ranee Thakar; Abdul H Sultan
Journal:  Int Urogynecol J       Date:  2015-04-11       Impact factor: 2.894

7.  Current management of pelvic organ prolapse in aging women: EMAS clinical guide.

Authors:  Andrea Giannini; Eleonora Russo; Antonio Cano; Peter Chedraui; Dimitrios G Goulis; Irene Lambrinoudaki; Patrice Lopes; Gita Mishra; Alfred Mueck; Margaret Rees; Levent M Senturk; John C Stevenson; Petra Stute; Pauliina Tuomikoski; Tommaso Simoncini
Journal:  Maturitas       Date:  2018-02-06       Impact factor: 4.342

8.  Long-term functional stability of sacrospinous ligament-fixation repair of pelvic organ prolapse.

Authors:  C Souviat; A Bricou; R Porcher; F Demaria; X Fritel; J-L Benifla; A Pigné
Journal:  J Obstet Gynaecol       Date:  2012-11       Impact factor: 1.246

Review 9.  Post-hysterectomy vaginal vault prolapse.

Authors:  Dudley Robinson; Gans Thiagamoorthy; Linda Cardozo
Journal:  Maturitas       Date:  2017-07-31       Impact factor: 4.342

10.  Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.

Authors:  José Luis Dueñas; Alessio Miceli
Journal:  Int Urogynecol J       Date:  2018-02-24       Impact factor: 2.894

View more
  5 in total

1.  What is known from the existing literature about self-management of pessaries for pelvic organ prolapse? A scoping review protocol.

Authors:  Lucy Dwyer; Dawn Dowding; R Kearney
Journal:  BMJ Open       Date:  2022-01-11       Impact factor: 2.692

2.  Clinical outcomes in patients with advanced pelvic prolapse who underwent LeFort surgery or pessary placement- A prospective cohort study.

Authors:  Elham Gholamian; Fedyeh Haghollahi; Samaneh Tarokh; Maryam Hajihashemy; Mamak Shariat
Journal:  Caspian J Intern Med       Date:  2022

3.  Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study.

Authors:  L R van der Vaart; A Vollebregt; A L Milani; A L Lagro-Janssen; R G Duijnhoven; J-Pwr Roovers; C H Van der Vaart
Journal:  BJOG       Date:  2021-10-28       Impact factor: 7.331

Review 4.  What are the barriers and facilitators to self-management of chronic conditions reported by women? A systematic review.

Authors:  Lucy Dwyer; Dawn Dowding; Rohna Kearney
Journal:  BMJ Open       Date:  2022-07-20       Impact factor: 3.006

5.  Theoretical and practical development of the TOPSY self-management intervention for women who use a vaginal pessary for pelvic organ prolapse.

Authors:  Lucy Dwyer; Carol Bugge; Suzanne Hagen; Kirsteen Goodman; Wael Agur; Melanie Dembinsky; Margaret Graham; Karen Guerrero; Christine Hemming; Aethele Khunda; Doreen McClurg; Lynn Melone; Ranee Thakar; Rohna Kearney
Journal:  Trials       Date:  2022-09-05       Impact factor: 2.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.